Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues

British Journal of Pharmacology
G J ChristA Melman

Abstract

1. The pathophysiology of impotence related to vascular smooth muscle dysfunction in the male corpus cavernosum was studied on human isolated erectile tissue (HET). Studies were conducted on 140 sections of HET obtained from 38 male patients undergoing surgery for implantation of penile prostheses to correct underlying erectile dysfunction. 2. Spontaneous myotonic oscillations were characteristic of greater than 90% of all HET preparations at 37 degrees C. These spontaneous oscillations were markedly attenuated by indomethacin, BW755C, nifedipine, removal of extracellular Ca2+, or lower temperatures (less than or equal to 32 degrees C), but were not sensitive to inhibition by atropine, phentolamine or tetrodotoxin. Our data suggest that the oscillations may, at least in part, result from the generation and/or release of a stable cyclo-oxygenase product and a consequent increase in transmembrane Ca2+ influx. 3. The phenylephrine-induced contractions in HET may be reliably assayed up to 24 h after surgical removal, without significant alterations in the EC50, maximum response (Emax) or slope index of the steady-state concentration-response curve to phenylephrine. 4. The competitive and surmountable nature of the antagonism of phe...Continue Reading

References

Jul 1, 1985·Acta Physiologica Scandinavica·H Hedlund, K E Andersson
Jan 1, 1987·Journal of Cardiovascular Pharmacology·P A van Zwieten
Jan 1, 1987·Journal of Cardiovascular Pharmacology·N K Hollenberg
Jan 1, 1987·Journal of Cardiovascular Pharmacology·P M Vanhoutte
Jul 1, 1988·Journal of Cardiovascular Pharmacology·Z S KatusicP M Vanhoutte
Apr 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J A BevanS M Shreeve
Oct 1, 1989·The Journal of Urology·Iñigo Sáenz de TejadaI Goldstein
Apr 20, 1989·The New England Journal of Medicine·Iñigo Sáenz de TejadaR A Cohen
Jan 1, 1988·Trends in Pharmacological Sciences·T GodfraindM Wibo
May 1, 1987·The Journal of Urology·T F Lue, E A Tanagho
Nov 1, 1987·The Journal of Urology·M FovaeusH Hedlund
Jul 1, 1986·The Journal of Urology·K P JuenemannE A Tanagho
Jun 1, 1981·Journal of Autonomic Pharmacology·P G Adaikan, S M Karim
Dec 1, 1982·Journal of Medicinal Chemistry·P B Timmermans, P A van Zwieten
Dec 1, 1984·British Journal of Pharmacology·N SatakeS Ueda
Jun 14, 2000·International Journal of Impotence Research·Iñigo Sáenz de TejadaA M Traish
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Jun 1, 1964·Circulation Research·M J BRODY, R L DIXON

Citations

Aug 6, 2010·Surgical and Radiologic Anatomy : SRA·Ayman AwadGérard Benoît
Sep 4, 2008·Sleep & Breathing = Schlaf & Atmung·Nikolaos ZiasAlexandra Chroneou
Aug 25, 2007·International Journal of Impotence Research·A F BradingHikaru Hashitani
Oct 2, 2001·BJU International·G Wagner, J Mulhall
Jun 20, 2001·BJU International·M E SullivanM A Miller
Jun 15, 2000·The New England Journal of Medicine·T F Lue
May 23, 2002·Clinical Neuropharmacology·Elliot M Frohman
Oct 1, 1994·British Journal of Urology·R S PickardP H Powell
Jul 1, 1997·The Journal of Urology·A A EsenZ Kirkali
Jul 5, 2005·Expert Opinion on Investigational Drugs·M A KhanD P Mikhailidis
Jan 14, 2009·The Journal of Sexual Medicine·G P SergeantK D Thornbury
Jul 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M A Miller, R J Morgan
Jan 21, 2006·The Journal of Sexual Medicine·Iñigo Sáenz de TejadaUlf Simonsen
Jul 18, 2002·Japanese Journal of Pharmacology·John A Thomas
Aug 2, 2002·International Journal of Impotence Research·S FilippiM Maggi
Sep 10, 2015·Clinical Pharmacology and Therapeutics·D J Hawksworth, A L Burnett
May 1, 1996·The Journal of Urology·D CahnG J Christ
Feb 26, 1999·The Journal of Urology·A Melman, J C Gingell
Apr 2, 2004·International Journal of Impotence Research·P RecioM Hernández
Jan 31, 2004·British Journal of Pharmacology·Hikaru Hashitani, Hikaru Suzuki
Aug 1, 1992·The Journal of Urology·R LuangkhotA Melman
Jun 1, 1993·The Journal of Urology·A C Campos de CarvalhoD C Spray
Sep 14, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Fábio H SilvaEdson Antunes
May 1, 1993·The Journal of Urology·S E LernerG J Christ
Aug 15, 2003·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Nandan KoppikerDavid Price

Related Concepts

Senility
Bay-K-8644, (+)-Isomer
Erectile Dysfunction
Osmosin
Inotropism
Muscle, Smooth, Vascular
Fenigidin
Nocturnal Penile Tumescence
Glans Penis
Mezaton

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.